Home Investors > News > Press Releases > Press Release Details

Press Release Details

Teva to Present at the NASDAQ OMX 27th Investor Program

December 5, 2011

JERUSALEM--(BUSINESS WIRE)--Dec. 5, 2011-- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) will host a live audio webcast at the NASDAQ OMX 27^th Investor Program with Eyal Desheh, Chief Financial Officer, Teva Pharmaceutical Industries Ltd., presenting on Tuesday, December 6, 2011 in London.

What:		Teva Presentation at the NASDAQ OMX 27^th Investor Program

Who:		Eyal Desheh, Chief Financial Officer, Teva Pharmaceutical Industries Ltd.

When:		Tuesday, December 6, 2011 at 5:15 am EST (10:15 am GMT)

Where:		http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Finvestor.shareholder.com%2FNDQCCG%2Flondon_dec2011%2Feventdetail.cfm%3Feventid%3D105938&esheet=50094829&lan=en-US&anchor=http%3A%2F%2Finvestor.shareholder.com%2FNDQCCG%2Flondon_dec2011%2Feventdetail.cfm%3Feventid%3D105938&index=1&md5=f30f863dc84f9e3b476b39f09908a9d0

How:		Live over the Internet – log on to the Web at the address above and register for the event (approx. 10 minutes before). An archive of the webcast will be available on Teva’s website.

About Teva

Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, Teva is the world's largest generic drug maker, with a global product portfolio of more than 1,300 molecules and a direct presence in about 60 countries. Teva's branded businesses focus on CNS, oncology, pain, respiratory and women's health therapeutic areas as well as biologics. Teva currently employs approximately 45,000 people around the world and reached $16.1 billion in net sales in 2010.